周焕然

Shape86Shape85Shape84Shape83Shape82Shape81Shape80Shape79Shape78Shape77Shape76Shape75Shape74Shape73Shape72Shape71Shape70Shape69Shape68Shape67Shape66Shape65Shape64Shape63Shape62Shape61Shape60Shape59Shape58Shape57Shape56Shape55Shape54Shape53Shape52Shape51Shape50Shape49Shape48Shape47Shape46Shape45Shape44Shape43Shape42Shape41Shape40Shape39Shape38Shape37Shape36Shape35Shape34Shape33Shape32Shape31Shape30Shape29Shape28Shape27Shape26Shape25Shape24Shape23Shape22Shape21Shape20Shape19Shape18Shape17Shape16Shape15Shape14Shape13Shape12Shape11Shape10Shape9Shape8Shape7Shape6Shape5Shape4Shape3Shape2Shape1





  • 研究组主要研究兴趣及方向:

1.糖尿病及其慢性并发症的机制研究;

2.代谢相关脂肪性肝病的机制研究。


  • 个人简况:

  1. 导师类型:科学学位硕士生导师

  2. 专业技术职称:副研究员、主治医师

  3. 行政职务:无

  4. 招生专业:内科学(内分泌与代谢病)

  5. 简介:

   博士,副研究员、主治医师。从事内分泌临床及基础研究多年,协助培养博士、硕士研究生多名。主持多项国家级、省级基金。以第一作者及通讯作者发表SCI论文及核心期刊多篇,参编著多部。


  • 联系方式:

E-mail:zhouhr@ustc.edu.cn

电话:-


  • 近五年发表重要学术论文:

  1. Zhou HR, Kuang HY. Circular RNAs: Novel target of diabetic retinopathy. Rev Endocr Metab Disord. 2021 Jun;22(2):205-216.

  2. Pang B (#),Zhou H (#), Kuang H.The potential benefits of glucagon-like peptide-1 receptor agonists for diabetic retinopathy. Peptides. 2018 Feb;100:123-126.



  • 本人承担在研科研项目:(仅限于主要负责人)

项目名称、来源

起止时间

总经费(万元)

HCAR2在糖尿病视网膜病变中介导小胶质细胞破坏血-视网膜屏障的机制研究,国家自然科学基金委

2025.01-2027.12

30